메뉴 건너뛰기
Paediatrics and Child Health
Volumn 17, Issue 3, 2012, Pages 147-150
Biologic response modifiers to decrease inflammation: Focus on infection risks
Author keywords

Immune modulators; Infection; Juvenile idiopathic arthritis; Macrophages; TNF ; Tuberculosis
Indexed keywords

ABATACEPT; ADALIMUMAB; BIOLOGICAL RESPONSE MODIFIER; CANAKINUMAB; CERTOLIZUMAB PEGOL; CYTOKINE; CYTOKINE RECEPTOR; ETANERCEPT; GOLIMUMAB; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; METHOTREXATE; NATALIZUMAB; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; STEROID; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; USTEKINUMAB;
EID: 84858198351     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/17.3.147     Document Type: Short Survey
Times cited : (16)
References (11)
  • 1
    • 37849052961 scopus 로고    scopus 로고
    • TNF-alpha blockade in human diseases: Mechanisms and future directions
    • Wong M, Ziring D, Korin Y, et al. TNF-alpha blockade in human diseases: Mechanisms and future directions. Clin Immunol 2008;126(2):121-36.
    • (2008) Clin Immunol , vol.126 , Issue.2 , pp. 121-136
    • Wong, M.1    Ziring, D.2    Korin, Y.3
  • 2
    • 42449095405 scopus 로고    scopus 로고
    • The risk of infection associated with tumor necrosis factor alpha antagonists: Making sense of epidemiologic evidence
    • DOI 10.1002/art.23396
    • Solomon DH, Lunt M, Schneeweiss S. The risk of infection associated with tumor necrosis factor alpha antagonists: Making sense of epidemiologic evidence. Arthritis Rheum 2008;58(4):919-28. (Pubitemid 351563992)
    • (2008) Arthritis and Rheumatism , vol.58 , Issue.4 , pp. 919-928
    • Solomon, D.H.1    Lunt, M.2    Schneeweiss, S.3
  • 3
    • 39749102391 scopus 로고    scopus 로고
    • Fungal infections complicating tumor necrosis factor alpha blockade therapy
    • DOI 10.4065/83.2.181
    • Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008;83(2):181-94. (Pubitemid 351303102)
    • (2008) Mayo Clinic Proceedings , vol.83 , Issue.2 , pp. 181-194
    • Tsiodras, S.1    Samonis, G.2    Boumpas, D.T.3    Kontoyiannis, D.P.4
  • 4
    • 67651125074 scopus 로고    scopus 로고
    • Infectious complications of tumor necrosis factor blockade
    • Wallis RS. Infectious complications of tumor necrosis factor blockade. Curr Opin Infect Dis 2009;22(4):403-9.
    • (2009) Curr Opin Infect Dis , vol.22 , Issue.4 , pp. 403-409
    • Wallis, R.S.1
  • 5
    • 79956215758 scopus 로고    scopus 로고
    • Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials
    • Thompson AE, Rieder SW, Pope JE. Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials. Arthritis Rheum 2011;63(6):1479-85.
    • (2011) Arthritis Rheum , vol.63 , Issue.6 , pp. 1479-1485
    • Thompson, A.E.1    Rieder, S.W.2    Pope, J.E.3
  • 7
    • 70349577776 scopus 로고    scopus 로고
    • Preventing and treating biologic-associated opportunistic infections
    • Winthrop KL, Chiller T. Preventing and treating biologic-associated opportunistic infections. Nat Rev Rheumatol 2009;5(7):405-10.
    • (2009) Nat Rev Rheumatol , vol.5 , Issue.7 , pp. 405-410
    • Winthrop, K.L.1    Chiller, T.2
  • 8
    • 70450208567 scopus 로고    scopus 로고
    • Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy
    • Chung SJ, Kim JK, Park MC, Park YB, Lee SK. Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy. J Rheumatol 2009;36(11):2416-20.
    • (2009) J Rheumatol , vol.36 , Issue.11 , pp. 2416-2420
    • Chung, S.J.1    Kim, J.K.2    Park, M.C.3    Park, Y.B.4    Lee, S.K.5
  • 9
    • 60749125474 scopus 로고    scopus 로고
    • Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents
    • Strangfeld A, Listing J, Herzer P, et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 2009;301(7):737-44.
    • (2009) JAMA , vol.301 , Issue.7 , pp. 737-744
    • Strangfeld, A.1    Listing, J.2    Herzer, P.3
  • 10
    • 57549110244 scopus 로고    scopus 로고
    • Foodborne Infections
    • Infectious Diseases and Immunization Committee. (Accessed August 18, 2011)
    • Moore DL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Foodborne Infections. Paediatr Child Health 2008;14(6):779-82. (Accessed August 18, 2011).
    • (2008) Paediatr Child Health , vol.14 , Issue.6 , pp. 779-782
    • Moore, D.L.1
  • 11
    • 0003859836 scopus 로고    scopus 로고
    • Public Health Agency of Canada. Seventh Edition - (Accessed August 18, 2011)
    • Public Health Agency of Canada. Canadian Immunization Guide, Seventh Edition - 2006. (Accessed August 18, 2011).
    • (2006) Canadian Immunization Guide

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.